Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
Alphatec operates as a spine-focused technology provider, developing advanced hardware and software solutions for complex surgical procedures. It differentiates itself through an integrated ecosystem, ...
Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...
MINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with ...
Medicare Part B covers the cost of Inspire for sleep apnea and other FDA-approved medical devices as long as a doctor determines them to be medically essential for your care. For Original Medicare to ...
Zacks Investment Research on MSN
INSP highlights new OSA data and PREDICTOR study at SLEEP 2026
Inspire Medical Systems INSP recently showcased new clinical data, technology advancements and cardiovascular outcomes research at SLEEP 2026, the annual meeting of the Associated Professional Sleep ...
Alphatec focuses on a comprehensive spine surgery ecosystem to capture market share through integrated imaging and surgical solutions. Inspire Medical Systems dominates the sleep apnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results